IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume
Condition(s):Pelvis TumorsLast Updated:August 17, 2018Recruiting
Hide Studies Not Open or Pending
Condition(s):Pelvis TumorsLast Updated:August 17, 2018Recruiting
Condition(s):Pelvic TumorLast Updated:April 30, 2019Recruiting
Condition(s):Abdominal Neoplasms; Pelvic NeoplasmsLast Updated:January 19, 2021Recruiting
Condition(s):Pain, ChronicLast Updated:September 3, 2020Completed
Condition(s):Cervical Cancer; Uterine Cancer; Ovarian CancerLast Updated:November 2, 2016Unknown status
Condition(s):Pelvic NeoplasmsLast Updated:August 4, 2020Recruiting
Condition(s):Abdominal Neoplasms; Pelvic NeoplasmsLast Updated:September 20, 2011Completed
Condition(s):Pelvic NeoplasmsLast Updated:January 5, 2015Completed
Condition(s):Malignant Abdominal Neoplasm; Malignant Pelvic Neoplasm; Recurrent Colon Carcinoma; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Gastric Carcinoma; Recurrent Liposarcoma; Recurrent Malignant Mesothelioma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Rectal Carcinoma; Recurrent Rhabdomyosarcoma; Recurrent Sarcoma; Refractory Colon Carcinoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Fallopian Tube Carcinoma; Refractory Gastric Carcinoma; Refractory Liposarcoma; Refractory Malignant Mesothelioma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal Carcinoma; Refractory Rectal Carcinoma; Refractory Rhabdomyosarcoma; Refractory Sarcoma; Resectable Liposarcoma; Resectable Malignant Mesothelioma; Resectable SarcomaLast Updated:May 29, 2020Recruiting
Condition(s):Pelvic MassLast Updated:June 23, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.